NCT04919421

Brief Summary

A split-mouth, controlled trial aimed to clinically compare and evaluate the effectiveness of virtual reality versus topical anesthesia gel prior to administration of dental anesthesia injection in reducing the perceived pain and anxiety level in adult patients and to find out their preferred procedure. Heart rate before and after the end of the procedure will be identified, pain intensity of the injection will be identified using a scale, and finally patients' preference will be identified using a questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

November 10, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

June 9, 2021

Completed
Last Updated

June 9, 2021

Status Verified

June 1, 2021

Enrollment Period

2 months

First QC Date

October 30, 2019

Last Update Submit

June 6, 2021

Conditions

Keywords

pain perceptionvirtual reality

Outcome Measures

Primary Outcomes (3)

  • Heart rate

    heart rate will be measured for the participants using an FDA Approved pulse oximeter (Santa Medical SM-165 Finger Pulse Oximeter)

    immediately after the intervention/procedure (injection)

  • Wong-Baker faces pain rating scale (WBFPS)

    A tool to measure the intensity of pain comprising a scale from 0 to 10. The patient will select a number based on the intensity of the pain, "0" means no pain, "10" means extremely severe pain.

    3 minutes after the intervention/procedure (injection)

  • Participant's future preference

    Each participant will be asked by a questionnaire to state his/her preference for the delivery system of future injections

    5 minutes after the intervention/procedure (injection)

Study Arms (2)

Virtual reality

ACTIVE COMPARATOR

Participants will wear a virtual reality headset during the dental injection in which a video is playing.

Device: Dental injection and virtual reality device

Topical gel

ACTIVE COMPARATOR

Participants will receive application of topical anesthetic gel on the site of dental injection.

Drug: Dental injection and topical gel application

Interventions

Topical anesthesia gel will be applied followed by dental injection with 1.8 ml Xylocaine 20mg/ml (DENSPLY Pharmaceutical); adrenaline: 1 : 100.000, delivered in cartridges using a 27 -gauge short needle (0.4 x 25 mm,C-K jet) and sterile non-aspirating syringe.

Also known as: No other name
Topical gel

Dental injection will be made while the participants are wearing virtual reality device.

Also known as: No other name
Virtual reality

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) class I, aged between 18 and 65, both male and female, who required bilateral local anesthetic injections in the premolar teeth in the upper jaw.
  • Participants are in good general health, take no medications, and have no contraindications to the use of local anesthetic.
  • The ability to understand oral and written instructions, and the ability to use the VR controller.

You may not qualify if:

  • Patients who need intravenous sedation cannot participate in the study.
  • If a patient requires only single visit/ treatment or if he/she cannot attend the other visit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riyadh Elm University

Riyadh, Saudi Arabia

Location

MeSH Terms

Conditions

Pain

Interventions

Dental Health Services

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Health ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Ammar AbuMostafa, BDS, MSC

    Riyadh Elm University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2019

First Posted

June 9, 2021

Study Start

November 10, 2019

Primary Completion

December 30, 2019

Study Completion

January 30, 2020

Last Updated

June 9, 2021

Record last verified: 2021-06

Locations